CYBB Human Pre-designed siRNA Set A contains three designed siRNAs for CYBB gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Cybb Mouse Pre-designed siRNA Set A contains three designed siRNAs for Cybb gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Cybb Rat Pre-designed siRNA Set A contains three designed siRNAs for Cybb gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

CYBC1 Human Pre-designed siRNA Set A contains three designed siRNAs for CYBC1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CYBRD1 Human Pre-designed siRNA Set A contains three designed siRNAs for CYBRD1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CYC1 Human Pre-designed siRNA Set A contains three designed siRNAs for CYC1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Cyclamic acid (sodium) (Standard) is the analytical standard of Cyclamic acid (sodium). This product is intended for research and analytical applications. Cyclamic acid (Cyclohexylsulfamic acid) sodium is one of the most widely used artificial sweetenersin food and pharmaceuticals[1].

Cyclic AC253 is an antagonist for amylin receptor, with IC50 of 0.3 μM. Cyclic AC253 exhibits neuroprotective efficacy against Aβ toxicity and abrogates Aβ-induced impairment of hippocampal long-term potentiation. Cyclic AC253 penetrate blood-brain barrier (BBB)[1].

Cyclic AMP-13C5 is a deuterated cyclic AMP.

Cyclo CKLIIF is a dual inhibitor for hypoxia inducible factor (HIF) 1 and 2, which disrupts the interaction of both HIF1-α and HIF2-α with HIF1-β, with affinity for HIF1-α and HIF2-α PAS-B domains KD of 2.6 and 2.2 μM, respectively[1].

Cyclo CRLLIF is a dual inhibitor for hypoxia inducible factor (HIF) 1 and 2, which disrupts the interaction of both HIF1-α and HIF2-α with HIF1-β, with affinity for HIF1-α and HIF2-α PAS-B domains KD of 14.5 and 10.2 μM, respectively[1].

Cyclo CRVIIF is a dual inhibitor for hypoxia inducible factor (HIF) 1 and 2, which disrupts the interaction of both HIF1-α and HIF2-α with HIF1-β, with affinity for HIF1-α and HIF2-α PAS-B domains KD of 65 and 123 μM, respectively[1].

Cyclovalone (Beveno) is a synthetic curcumin derivate, which inihibits cyclooxygenase and exhibits anti-inflammatory, antitumor and antioxidant activities[1]. Cyclovalone inhibits cell proliferation in normal and malignant prostatic cells. Cyclovalone ist orally active[2].

CYCS Human Pre-designed siRNA Set A contains three designed siRNAs for CYCS gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CYFIP1 Human Pre-designed siRNA Set A contains three designed siRNAs for CYFIP1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CYFIP2 Human Pre-designed siRNA Set A contains three designed siRNAs for CYFIP2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CYGB Human Pre-designed siRNA Set A contains three designed siRNAs for CYGB gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CYLD Human Pre-designed siRNA Set A contains three designed siRNAs for CYLD gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Cynanoside J is a C21 steroidal glycosides that can be obtained from Cynanchum taihangense. The IC50 values of Cynanoside J for HL-60, THP1, and Caco2 are 6.38, 5.82, and 6.76 μM, respectively. Cynanoside J can be used in cancer research[1].

Cynaroside (Standard) is the analytical standard of Cynaroside. This product is intended for research and analytical applications. Cynaroside (Luteolin 7-glucoside) is a flavonoid compound that exhibits anti-oxidative capabilities. Cynaroside is also a potent influenza RNA-dependent RNA polymerase inhibitor with an IC50 of 32 nM. Cynaroside also is a promising inhibitor for H2O2-induced apoptosis, has cytoprotection […]

CYP11A1 Human Pre-designed siRNA Set A contains three designed siRNAs for CYP11A1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CYP11B1 Human Pre-designed siRNA Set A contains three designed siRNAs for CYP11B1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CYP11B2 Human Pre-designed siRNA Set A contains three designed siRNAs for CYP11B2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CYP17A1 Human Pre-designed siRNA Set A contains three designed siRNAs for CYP17A1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CYP17A1/HDAC6-IN-1 (compound 12) is a potent inhibitor of CYP17A1/HDAC6, with IC50 of 0.284μM and 0.6015 μM,respectively. CYP17A1/HDAC6-IN-1 has anti-tumor activity[1].

CYP19A1 Human Pre-designed siRNA Set A contains three designed siRNAs for CYP19A1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Cyp19a1 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Cyp19a1 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

CYP19A1 Rat Pre-designed siRNA Set A contains three designed siRNAs for CYP19A1 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

CYP1A1 Human Pre-designed siRNA Set A contains three designed siRNAs for CYP1A1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CYP1A2 Human Pre-designed siRNA Set A contains three designed siRNAs for CYP1A2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CYP1B1 Human Pre-designed siRNA Set A contains three designed siRNAs for CYP1B1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CYP1B1-IN-7 (compound 2a) is a selective inhibitor of CYP1B1 (IC50: 75 nM). CYP1B1-IN-7 also reverses resistance (IC50: 29 μM) and exhibits cytotoxicity in the CYP1B1-overexpressing MCF-7 cell line that is resistant to Docetaxel (HY-B0011)[1].

CYP1B1-IN-8 (Compound 14b) is a CYP1B1 inhibitor (IC50: 4.14 × 10–5 nM). CYP1B1-IN-8 reduces the resistance in A549 cells to Paclitaxel (HY-B0015), and inhibits cell migration and invasion[1].

CYP20A1 Human Pre-designed siRNA Set A contains three designed siRNAs for CYP20A1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CYP21A2 Human Pre-designed siRNA Set A contains three designed siRNAs for CYP21A2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CYP24A1 Human Pre-designed siRNA Set A contains three designed siRNAs for CYP24A1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CYP26A1 Human Pre-designed siRNA Set A contains three designed siRNAs for CYP26A1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CYP26B1 Human Pre-designed siRNA Set A contains three designed siRNAs for CYP26B1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CYP26C1 Human Pre-designed siRNA Set A contains three designed siRNAs for CYP26C1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.